文献速递头颈外科

抗生素处方与头颈癌诊断时间的关联

Association Between Antibiotic Prescribing and Time to Diagnosis of Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2023-01-01

该回顾性队列研究纳入7811例头颈癌患者,发现15.6%在诊断前3个月内至少被开具1次抗生素处方,高于诊断前12至9个月基线期的8.9%。诊断前3个月内接受抗生素处方者从症状出现到诊断的时间延长21.1%(ARR 1.21;95%CI 1.14-1.29)。

要点

  • 头颈癌诊断前3个月内15.6%患者被开具抗生素,高于基线期8.9%。
  • 诊断前3个月内抗生素处方与症状出现至诊断时间延长21.1%相关(ARR 1.21;95%CI 1.14-1.29)。
  • 以颈部肿块/肿胀就诊者中,有其他症状者从症状出现至诊断的间隔更长(ARR 1.31;95%CI 1.08-1.59)。

核心结论

  • 该队列研究结果提示头颈癌诊断前3个月内抗生素处方率升高,且与诊断时间延长相关。
  • 这些发现确定了头颈癌诊疗和指南中一个可改进的领域。

研究设计与样本

  • 回顾性队列研究,使用2011年1月1日至2018年12月31日的去标识化电子健康记录数据集。
  • 纳入诊断日期前至少在数据集中入组1年的头颈癌患者,诊断日期由6个月内1次住院就诊或2次门诊就诊中的首次确定。
  • 数据分析于2022年5月1日至11月9日进行。
  • 暴露为头颈癌诊断日期前3个月内开具抗生素处方。

主要发现

  • 队列纳入7811例头颈癌患者,其中男性4151例(53.1%),平均(SD)年龄60.2(15.8)岁。
  • 1219例患者(15.6%)在头颈癌诊断前3个月内至少被开具1次抗生素处方。
  • 诊断前3个月内抗生素处方率较诊断前12至9个月基线期的8.9%有所增加。
  • 诊断前3个月内抗生素处方率随时间无显著变化(季度百分比变化0.49%;95%CI -3.06%至4.16%)。
  • 与耳鼻咽喉科医生诊断相比,初级保健/内科医生最可能为以首发症状就诊的患者开具抗生素(调整患病率比1.60;95%CI 1.27-2.02)。

关键数值与推荐

  • 主要结局为从首次记录症状至头颈癌诊断的天数。
  • 诊断前3个月内接受抗生素处方者从症状出现至头颈癌诊断的时间延长21.1%(ARR 1.21;95%CI 1.14-1.29)。
  • 在表现为颈部肿块/肿胀的患者中,表现为其他症状者从症状出现至诊断的间隔更长(ARR 1.31;95%CI 1.08-1.59)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Diagnostic delay can negatively affect patient outcomes in head and neck cancer (HNC). Neck mass and other symptoms of undiagnosed HNC may be treated with antibiotics, delaying diagnosis and treatment, despite current clinical practice guidelines. OBJECTIVE: To investigate temporal trends, associated factors, and time from symptom onset to antibiotic prescribing before an HNC diagnosis. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was conducted using data obtained from a deidentified electronic health records data set from January 1, 2011, to December 31, 2018. Patients with HNC enrolled in the data set for at least 1 year before diagnosis date determined by either 1 inpatient encounter or first of 2 outpatient encounters within 6 months were included. Data analysis was conducted from May 1 to November 9, 2022. EXPOSURE: Antibiotic prescription within 3 months before HNC diagnosis date. MAIN OUTCOMES AND MEASURES: The primary outcome was days from the first documented symptom to HNC diagnosis. RESULTS: The cohort included 7811 patients with HNC (4151 [53.1%] men, mean [SD] age, 60.2 [15.8] years). At least 1 antibiotic was prescribed for 1219 patients (15.6%) within 3 months before HNC diagnosis. This represented an increase over the 8.9% prescribing rate during the baseline period 12 to 9 months before diagnosis. The rate of antibiotic prescribing within 3 months before diagnosis did not change significantly over time (quarterly percent change, 0.49%; 95% CI, -3.06% to 4.16%). Patients receiving an antibiotic prescription within 3 months of an HNC diagnosis had a 21.1% longer time between symptom onset and HNC diagnoses (adjusted rate ratio [ARR], 1.21; 95% CI, 1.14-1.29). Compared with diagnosis by otolaryngologists, primary care/internal medicine physicians were most likely to prescribe antibiotics for patients who were diagnosed with a presenting symptom (adjusted prevalence ratio, 1.60; 95% CI, 1.27-2.02). In patients presenting with neck mass/swelling, those presenting with other symptoms were more likely to have longer intervals from symptom onset to diagnosis (ARR, 1.31; 95% CI, 1.08-1.59). CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest there is an increased rate of antibiotic prescription in the 3 months before HNC diagnosis, which is associated with an increased time to diagnosis. These findings identify an area for improvement in HNC care and guidelines.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Gallogly JA, Armstrong AT, Brinkmeier JV, et al. Association Between Antibiotic Prescribing and Time to Diagnosis of Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37615970. doi:10.1001/jamaoto.2023.2423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。